logo image
search icon
GMP Cell Therapy Consumables Market

GMP Cell Therapy Consumables Market Size, Share & Trends Analysis Report By Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy, Process, End User, Region, And Segment Forecasts, 2024-2031

Report ID : 1929 | Published : 2024-09-24 | Pages: 180 | Format: PDF/EXCEL

GMP Cell Therapy Consumables Market Size is valued at USD 17.61 Bn in 2023 and is predicted to reach USD 137.97 Bn by the year 2031 at a 29.8% CAGR during the forecast period for 2024-2031.

gmp cell therapy

Good Manufacturing Practices (GMP) ensure that products are manufactured and maintained under good quality standards. Cell therapy development processes are complex and require good pharmaceutical systems and quality control (QC).

The market growth is attributed to rising drug discovery, the high prevalence of cancer, cell therapy innovations, and the surging use of cell therapy & GMP cell therapy consumables. However, stringent regulatory policies may hamper the market growth. The increasing collaborations & partnership activities within companies operating in the GMP cell therapy consumables market for developing new products and cell therapy treatments also support the market growth. For instance, in March 2022, FUJIFILM Irvine Scientific, Inc. acquired Shenandoah Biotechnology, Inc., a leading manufacturer of recombinant proteins. Shenandoah Biotechnology recently launched their CTG Grade line of cytokines & growth factors manufactured according to cGMP guidelines in the company's new state-of-the-art, ISO 9001:2015 certified facility.

Moreover, the last five years have been a rebirth for cell therapy and gene therapy (CGT) innovation, and the COVID-19 pandemic has accelerated these developments. 

Competitive Landscape:

Some of the Key Players in the GMP Cell Therapy Consumables Market:

  • Sartorius AG
  • Thermo Fisher Scientific Inc     
  • Miltenyi Biotec BV & Co KG
  • Bio-Techne Corp
  • Corning Inc
  • FUJIFILM Irvine Scientific Inc
  • Lonza Group AG
  • BPS Bioscience Inc
  • Merck KGaA                            
  • Global Life Sciences Solutions USA LLC.
  • Other Prominent Players

Market Segmentation:

The GMP Cell Therapy Consumables Market is segmented into Product, cell therapy, Process, and end user. By Product, the market is categorized into kits, reagents/molecular biology reagents, growth factors/cytokines and interleukins, and others. The cell therapy segment comprises NK cell therapy, stem cell therapy, T-cell therapy, and others. By Process, the market is divided into cell collection and characterization/sorting and separation, cryopreservationcell culture and expansion/preparation, cell processing and formulation, cell distribution/handling, cell isolation and activation, process monitoring and control/readministration/quality assurance, and others. The end user segment consists of clinical, commercial, and research.

By Product, The Kits Segment Held The Largest Market Share In 2022

The kits segment held the largest GMP cell therapy consumables market share in 2022. However, the growth factors/cytokines and interleukins segment is predicted to capture the highest CAGR over the forecast period.

By Cell Therapy, The T-Cell Therapy Segment Held The Largest Market Share

In 2022, the T-cell therapy segment held the largest share of the GMP cell therapy consumables market. Various clinical trials on Chimeric antigen receptor (CAR) T-cell therapy are being conducted for cancer treatment. The therapy improves the immune system's power, protecting against infections by destroying harmful viruses & bacteria. Such increasing clinical trials of CAR T-cell therapy are surging the demand for GMP cell therapy consumables.

By Process, The Cell Collection And Characterization/Sorting And Separation Segment Is Expected To Drive The GMP Cell Therapy Consumables Market

The cell collection, characterization/sorting, and separation segment are expected to drive the market during the forecast period. Moreover, the cryopreservation segment is anticipated to grow fastest in the coming years. Several companies in this market are building the GMP-compliant cell sorter to reduce contamination.

In Terms Of End Users, The Clinical Segment Dominates The Market

In 2022, the clinical segment led the GMP cell therapy consumables market. Increasing clinical trials due to the high prevalence of chronic diseases, rising clinical studies and research efforts for developing new cell therapies are expected to enhance the market growth over the projected period. 

Regionally, North America Led The GMP Cell Therapy Consumables Market

Factors such as the increasing demand for cell therapies, the surging use of GMP cell therapy consumables, and rising research efforts in drug discoveries are responsible for the blooming of the GMP Cell Therapy Consumables Market in North America. At the same time, the Asia Pacific regional market is predicted to register the swiftest growth in the upcoming years. Growing cancer cases, chronic diseases, autoimmune disorders, and infectious diseases, increasing adoption of GMP cell therapy consumable products in India, and the development of cell therapy products are among the factors supporting the growth of the GMP Cell Therapy Consumables Market in this region.

GMP Cell Therapy Consumables Market Report Scope:

Report Attribute

Specifications

Market Size Value In 2023

USD 17.61 Bn

Revenue Forecast In 2031

USD 137.97 Bn

Growth Rate CAGR

CAGR of 29.8 % from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Million and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Product, By Cell Therapy, By Process, By End User

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; South East Asia

Competitive Landscape

Sartorius AG, Thermo Fisher Scientific Inc., Miltenyi Biotec BV & Co KG, Bio-Techne Corp, Corning Inc., FUJIFILM Irvine Scientific Inc., Lonza Group AG, BPS Bioscience Inc., Merck KGaA, Global Life Sciences Solutions USA LLC., and Others

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing and Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global GMP Cell Therapy Consumables Market Snapshot

Chapter 4. Global GMP Cell Therapy Consumables Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of Metaverse Industry
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact on Metaverse Industry

Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis
5.1. By Product & Market Share, 2023-2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Product:

5.2.1. Kits
5.2.2. Reagents/Molecular Biology Reagents
5.2.3. Growth Factors/Cytokines and Interleukins
5.2.4. Others

Chapter 6. Market Segmentation 2: By Cell Therapy Estimates & Trend Analysis
6.1. By Product & Market Share, 2023-2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Cell Therapy:

6.2.1. NK Cell Therapy
6.2.2. Stem Cell Therapy
6.2.3. T-Cell Therapy
6.2.4. Others

Chapter 7. Market Segmentation 3: By Process Estimates & Trend Analysis
7.1. By Product & Market Share, 2023-2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Process:

7.2.1. Cell Collection and Characterization/Sorting and Separation
7.2.2. Cell Culture and Expansion/Preparation
7.2.3. Cryopreservation
7.2.4. Cell Processing and Formulation
7.2.5. Cell Isolation and Activation
7.2.6. Cell Distribution/Handling
7.2.7. Others

Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. By Product & Market Share, 2023-2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End User:

8.2.1. Clinical
8.2.2. Commercial
8.2.3. Research

Chapter 9. GMP Cell Therapy Consumables Market Segmentation 5: Regional Estimates & Trend Analysis

9.1. North America

9.1.1. North America GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts By Product, 2024-2031
9.1.2. North America GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts By Cell Therapy, 2024-203
9.1.3. North America GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts By Process, 2024-2031
9.1.4. North America GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts By, End User 2024-2031
9.1.5. North America GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts by country, 2024-2031

9.1.5.1. U.S.
9.1.5.2. Canada

9.2. Europe

9.2.1. Europe GMP Cell Therapy Consumables Market revenue (US$ Million) by By Product, 2024-2031
9.2.2. Europe GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts By Cell Therapy, 2024-2031
9.2.3. Europe GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts By Process 2024-2031
9.2.4. Europe GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts By End User,2024-2031
9.2.5. Europe GMP Cell Therapy Consumables Market revenue (US$ Million) by country, 2023-2031

9.2.5.1. Germany
9.2.5.2. Poland
9.2.5.3. France
9.2.5.4. Italy
9.2.5.5. Spain
9.2.5.6. UK
9.2.5.7. Rest of Europe

9.3. Asia Pacific

9.3.1. Asia Pacific GMP Cell Therapy Consumables Market revenue (US$ Million) by By Product, 2024-2031
9.3.2. Asia Pacific GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts By Cell Therapy, 2024-2031
9.3.3. Asia Pacific GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts By Process, 2024-2031
9.3.4. Asia Pacific GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts By End User, 2024-20
9.3.5. Asia Pacific GMP Cell Therapy Consumables Market revenue (US$ Million) by country, 2024-2031

9.3.5.1. China
9.3.5.2. India
9.3.5.3. Japan
9.3.5.4. Australia
9.3.5.5. Rest of Asia Pacific


9.4. Latin America

9.4.1. Latin America GMP Cell Therapy Consumables Market revenue (US$ Million) by By Product, 2024-2031
9.4.2. Latin America GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts By Cell Therapy, 2024-2031
9.4.3. Latin America GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts By Process, 2024-2031
9.4.4. Latin America GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts By End User, 2024-2031
9.4.5. Latin America GMP Cell Therapy Consumables Market revenue (US$ Million) by country, (US$ Million) 2024-2031

9.4.5.1. Brazil
9.4.5.2. Rest of Latin America

9.5. Middle East & Africa

9.5.1. Middle East & Africa GMP Cell Therapy Consumables Market revenue (US$ Million) by By Product, 2024-2031
9.5.2. Middle East & Africa GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts By Cell Therapy, 2024-2031
9.5.3. Middle East & Africa GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts By Process, 2024-2031
9.5.4. Middle East & Africa GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts By End User, 2024-2031
9.5.5. Middle East & Africa GMP Cell Therapy Consumables Market revenue (US$ Million) by country, (US$ Million) 2024-2031

9.5.5.1. South Africa
9.5.5.2. GCC Countries
9.5.5.3. Rest of MEA

Chapter 10. Competitive Landscape

10.1. Major Mergers and Acquisitions/Strategic Alliances

10.2. Company Profiles


10.2.1. Sartorius AG
10.2.2. Thermo Fisher Scientific Inc
10.2.3. Miltenyi Biotec BV & Co KG
10.2.4. Bio-Techne Corp
10.2.5. Corning Inc
10.2.6. FUJIFILM Irvine Scientific Inc
10.2.7. Lonza Group AG
10.2.8. BPS Bioscience Inc
10.2.9. Merck KGaA
10.2.10. Global Life Sciences Solutions USA LLC
10.2.11. Other Prominent Players

Segmentation of GMP Cell Therapy Consumables Market-

GMP Cell Therapy Consumables Market By Product-

  • Kits
  • Reagents/Molecular Biology Reagents
  • Growth Factors/Cytokines and Interleukins
  • Others

gmp cell therapy

GMP Cell Therapy Consumables Market By Cell Therapy-

  • NK Cell Therapy
  • Stem Cell Therapy
  • T-Cell Therapy
  • Others

GMP Cell Therapy Consumables Market By Process-

  • Cell Collection and Characterization/Sorting and Separation
  • Cell Culture and Expansion/Preparation
  • Cryopreservation
  • Cell Processing and Formulation
  • Cell Isolation and Activation
  • Cell Distribution/Handling
  • Process Monitoring and Control/Readministration/Quality Assurance
  • Others

GMP Cell Therapy Consumables Market By End User-

  • Clinical
  • Commercial
  • Research

GMP Cell Therapy Consumables Market By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

 InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

 

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the GMP Cell Therapy Consumables Market?

GMP Cell Therapy Consumables Market is expected to grow at a 29.8% CAGR during the forecast period for 2024-2031

Sartorius AG, Thermo Fisher Scientific Inc., Miltenyi Biotec BV & Co KG, Bio-Techne Corp, Corning Inc., FUJIFILM Irvine Scientific Inc.,

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Biotechnology

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach